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Abstract
Background: Genome-wide studies have identified several common genetic variants that are robustly associated with adult
obesity risk. Exploration of these genotype associations in children may provide insights into the timing of weight changes
leading to adult obesity.
Methods and Findings: Children from the Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort were
genotyped for ten genetic variants previously associated with adult BMI. Eight variants that showed individual associations
with childhood BMI (in/near: FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5) were used to derive an
‘‘obesity-risk-allele score’’ comprising the total number of risk alleles (range: 2–15 alleles) in each child with complete
genotype data (n= 7,146). Repeated measurements of weight, length/height, and body mass index from birth to age 11
years were expressed as standard deviation scores (SDS). Early infancy was defined as birth to age 6 weeks, and early infancy
failure to thrive was defined as weight gain between below the 5th centile, adjusted for birth weight. The obesity-risk-allele
score showed little association with birth weight (regression coefficient: 0.01 SDS per allele; 95% CI 0.00–0.02), but had an
apparently much larger positive effect on early infancy weight gain (0.119 SDS/allele/year; 0.023–0.216) than on subsequent
childhood weight gain (0.004 SDS/allele/year; 0.004–0.005). The obesity-risk-allele score was also positively associated with
early infancy length gain (0.158 SDS/allele/year; 0.032–0.284) and with reduced risk of early infancy failure to thrive (odds
ratio = 0.92 per allele; 0.86–0.98; p= 0.009).
Conclusions: The use of robust genetic markers identified greater early infancy gains in weight and length as being on the
pathway to adult obesity risk in a contemporary birth cohort.
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Introduction
The increasing prevalence of overweight and obesity even in
young preschool children [1] highlights the need to understand the
very early determinants and potential targets for prevention of
obesity. It has been proposed that there are certain critical periods
in childhood for the development of obesity, including gestation
and early infancy, the period of adiposity rebound between ages 5
and 7 years, and adolescence [2]. However, the relevance of
overweight and obesity in infants and very young children to adult
obesity and its comorbidities is unclear [3]. Common genetic
variation associated with adult obesity may provide an opportunity
to identify the timing of childhood weight changes that are
associated with later obesity risk.
Recent technological advances and the massive increases in
scale and statistical rigour of genome-wide association (GWA)
studies has allowed the identification of common genetic variants
associated with adult BMI and obesity risk that are consistently
replicable in other populations. The first such common genetic
variation shown to be associated with adult body mass index (BMI)
was in the FTO gene region, published in 2007 by Frayling et al.
[4]. This was closely followed by variation downstream of MC4R
in 2008 [5]. Several further loci, in or near TMEM18, GNPDA2,
KCTD15, NEGR1, BDNF, ETV5, MTCH2, and SH2B1, were
recently reported to be adult obesity risk variants by studies from
the GIANT international consortium [6] and the deCODE
Genetics group [7].
To date all the published GWA-BMI studies primarily focussed
on the association with adult BMI. The initial reports of common
variants in/near to FTO and MC4R also included a demonstration
of their relevance to childhood BMI and childhood obesity [4,5],
and these have since been confirmed in other childhood studies
[8,9]. A further four of the six new variants for adult BMI
identified by the GIANT consortium also showed association with
childhood BMI and/or childhood obesity (TMEM18, GNPDA2,
KCTD15, and NEGR1) [6]. However, the joint publication by
deCODE Genetics did not include any childhood populations [7].
Although cross-sectional associations with childhood BMI have
been reported [4–6], the effects for most of these obesity risk
variants on the rate of growth and weight gain during infancy and
childhood have not yet been established. Data from the
population-based Avon Longitudinal Study of Parents and
Children (ALSPAC) birth cohort and other childhood obesity
studies have shown the relevance of individual variants in FTO [4],
MC4R [5], TMEM18, GNPDA2, KCTD15, and NEGR1 [6] for
childhood BMI and body fat mass. By further analysing these adult
obesity susceptibility loci in the ALSPAC birth cohort, with the
addition of variants in BDNF and ETV5 [7], we aimed to identify
the specific timing of childhood weight gain and growth associated
with adult obesity risk. As the effects of individual variants are
small (in the original studies of adult BMI the replication
populations numbered in the tens of thousands [4–7]), we used a
composite score of obesity risk alleles to maximise statistical power
and reduce multiple testing.
Methods
Study Population
ALSPAC is a prospective study that has been described in detail
elsewhere [10] (http://www.alspac.bris.ac.uk). Briefly, 14,541
pregnant women living in one of three Bristol-based health districts
in the former County of Avon with an expected delivery date
between April 1991 and December 1992 were enrolled in the study.
Detailed information has been collected using self-administered
questionnaires, data extraction from medical notes, and linkage to
routine information systems and at research clinics. Ethical approval
for the study was obtained from the ALSPAC Law and Ethics
Committee and Local Research Ethics Committees.
Growth Measurements
Infancy/early childhood. Birth weight as recorded in the
delivery room was obtained from medical records. Birth length
was measured by the study team. Infant and early childhood
measures of weight and length (up to age 2 y) or height (from 2 y)
at around ages 6 wk, 9 mo, and 1.5 and 3.5 y were available from
routinely collected measurements performed by health visitors as
part of the infant health surveillance programme and were
extracted from the local child health database.
Later childhood. Childhood weight and height was
measured annually between ages 7 and 11 y at dedicated
ALSPAC Focus clinics by a trained research team. Height was
measured to the nearest 0.1 cm using a Leicester Height Measure
(Holtain Crosswell, Dyfed) and weight while wearing underwear
was measured to the nearest 0.1 kg using Tanita electronic scales.
Fat mass and fat-free mass was assessed at the 9-year-old research
clinic visit by whole body dual energy X-ray absorptiometry
(DXA) (Prodigy scanner, Lunar Radiation Corp, Madison,
Wisconsin, US).
Genotypes
Genotype information was available for six GWA-obesity
variants previously reported to show association with BMI or
obesity in children [4–6]; these variants were: rs9939609 (in/near
to FTO); rs17782313 (MC4R), rs6548238 (TMEM18), rs10938397
(GNPDA2), rs368794 (KCTD15), rs2568958 (NEGR1). New geno-
type information was generated for two further variants reported
to be associated with BMI in adults: rs925946 (BDNF) and
rs7647305 (ETV5) [7]. Genotyping was performed by KBios-
ciences Ltd (Hoddesdon, UK) using their own novel system of
fluorescence-based competitive allele-specific PCR (KASPar).
Details of assay design are available from the KBiosciences Web
site (http://www.kbioscience.co.uk). Call rates were 93.3% for
rs925946 (BDNF) and 92.3% for rs7647305 (ETV5). All genotype
frequencies met Hardy-Weinberg Equilibrium criteria (p.0.1).
Calculations
BMI was calculated as weight (kg)/height2 (m2). Individual
weight, length/height, and BMI values were converted to standard
deviation scores (SDS) by comparison to the British 1990 growth
reference, adjusted for sex and precise age at measurement
[11,12]. Values at birth were adjusted for gestational age using the
growth reference. Children were classified as overweight or obese
based on the International Obesity Task Force (IOTF) criteria,
which uses population centile-based curves that pass through the
25 kg/m2 and 30 kg/m2 thresholds at age 18 y [13]. Fat and fat-
free mass indices were calculated for each child from DXA
measurements at age 9 y by dividing fat mass and fat-free mass (kg)
by height squared (m2) [14].
Weight gain from birth to 6 wk, conditional on birth
weight, was calculated using the following formula: SDSgain~
SDS6wk{r|SDSbirthð Þ
. ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1{r2
p
[15]. SDSbirth represents weight
SDS at birth, SDS6week weight SDS at the 6 wk measurement and
r represents the population correlation between weight SDS at
birth and 6 wk. The resulting SDSgain represents a measure of
weight gain from birth that is conditional on birth weight. Early
infancy ‘‘failure to thrive’’ was defined as infants with the slowest
5% conditional weight gain from birth within the ALSPAC
population [16].
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Statistical Analysis
Analyses were restricted to singleton white Europeans plus one
randomly selected child from each mother for whom more than
one child had entered the study. Linear regression was used to
analyse whether common genetic variants in BDNF (rs925946) and
ETV5 (rs7647305) showed cross-sectional associations with BMI,
weight, height, and body composition at 9 y.
An ‘‘obesity-risk-allele score’’ was created by counting the total
number of obesity risk alleles across the eight variants that showed
association with childhood weight or BMI (in/near to: FTO,
MC4R, TMEM18, GNPDA2, NEGR1, KCTD15, BDNF, and ETV5).
Only one variant at each locus was chosen and only individuals
with complete genotype data at all eight variants were included in
the obesity-risk-allele score analyses (n=7,146 children). A
‘‘weighted obesity-risk-allele-score’’ (where contributions of each
variant were weighted according to their apparent effect size on
adult BMI) showed essentially the same associations as the
currently reported unweighted score (unpublished data). For
comparison, a second obesity-risk-allele score was created based
on all ten variants (i.e., with the addition of the two variants in/
near SH2B1 and MTCH2 with no evidence for association with
childhood BMI or obesity [6]).
Linear regression was used to analyse the association between
the obesity-risk-allele score and weight, height, and BMI SDS, and
with fat mass index and fat-free mass index at age 9 y with
adjustment for sex, precise age at measurement, and height.
Logistic regression was used to analyse the association between the
obesity-risk-allele score and the risks of infancy failure to thrive,
and overweight or obesity at age 9 y.
Longitudinal analyses of associations between the obesity-risk-
allele score and rates of weight gain were performed using the
xtmixed command in STATA 10.1 to fit random intercepts models
[17]. By assigning a unique identifier for each individual, this
command performs a multi-level mixed effects linear regression
analysis, allowing for clustering within individuals. A risk-score6
age interaction term was calculated and added to the xtmixed
models. This interaction term denotes by how much the effect of
the obesity-risk-allele score gets stronger per year, and can be
interpreted as the effect of the obesity-risk-allele score on linear
change in weight SDS with age (in years). In further models,
additional polynomial interaction terms (risk-score 6 age2 and
risk-score 6 age3) were not significant (unpublished data). All
analyses were conducted using STATA version 10.1 [17].
Results
The ALSPAC Population
Characteristics of the ALSPAC sample of children (n=7,146)
with complete genotype data are described in Table 1. Compared
to other white European ALSPAC children without genotype data
(n=6,090), participants in this sample were slightly heavier at birth
and showed modest differences in childhood BMI (,0.1 SDS
difference at any age); their mothers were slightly older and more
educated, but there was no difference in maternal BMI (see Table
S1). The prevalence of obesity at age 9 y by IOTF criteria was
3.9% and 4.0% in boys and girls, respectively. At the same age,
20.0% of boys and 20.2% of girls met the IOTF criteria for
overweight or obese (Table 1).
Association of BDNF and ETV5 with Childhood BMI
Variants in rs925946 (BDNF) and rs7647305 (ETV5), which
have not been previously studied in children, were associated with
childhood BMI SDS, weight SDS, and height SDS (see Table S2).
For example, at age 9 y each obesity-risk-allele at rs925946 was
associated with +0.07 SDS (95% CI 0.03–0.12) greater childhood
BMI, and +0.06 SDS (0.01–0.12) for rs7647305.
The Obesity-Risk-Allele Score
The obesity-risk-allele score based on genotypes at eight SNPs
associated with childhood BMI (in/near to: FTO, MC4R,
TMEM18, GNPDA2, NEGR, KCTD15, BDNF, and ETV5) ranged
from 2 to 15 alleles. The score approximated a normal distribution
and showed a linear association with BMI SDS at age 9 y
(Figure 1). On average, each additional obesity risk allele conferred
an estimated 0.07 SDS greater weight (95% CI 0.05–0.08;
p=1.2610217), 0.08 SDS greater BMI (0.06–0.10; p=1.4610219),
and 0.03 SDS greater height (0.01–0.04; p=0.0003) at age 9 y. The
differences in body size at age 9 y between the two extreme groups
displayed in Figure 1 (#4 risk alleles versus$13 risk-alleles) equated
to 3.5 kg in body weight, 1.4 kg/m2 in BMI, and 2.0 cm in height at
age 9 y. The obesity-risk-allele score explained 1.7% of the variance
in BMI SDS at age 9 y (see Table S3). Furthermore, the obesity-
risk-allele score was associated with increased risk of childhood
overweight (odds ratio [OR] per allele = 1.14; 95% CI 1.10–1.19;
p=6.3610211) and childhood obesity (OR=1.17; 1.07–1.26;
p=0.0002) at age 9 years, and was more strongly associated with
childhood fat mass index (0.13 kg/m2 per allele; 0.10–0.16,
adjusted for sex, age, and height) than with fat-free mass index
(0.03 kg/m2 per allele; 0.01–0.04) (Table 2).
Rate of Infancy and Childhood Weight Gain
The obesity-risk-allele score showed little association with birth
weight SDS (effect size 0.01 SDS per allele; 95% CI 0.00–0.02;
p=0.2), but showed increasing positive associations with weight
SDS from early infancy to childhood (Figure 2A). Even as early as
age 6 wk, each additional risk allele was associated with a 0.03
SDS increase in weight (95% CI 0.01–0.04; p=0.001).
Longitudinal analyses estimated that the obesity-risk-allele score
was positively associated with rate of weight gain between birth to
age 11 y (0.005 SDS/allele/y; 95% CI 0.004–0.006). The obesity-
risk-allele score had an apparent much larger effect on the rate of
early infancy weight gain (birth to 6 wk: 0.119 SDS/allele/y;
0.023–0.216) than on subsequent weight gain (6 wk to 11 y: 0.004
SDS/allele/y; 0.004–0.005).
The obesity-risk-allele score was positively associated with
conditional weight gain between birth and age 6 wk (0.03 SDS
gain per allele, 0.01–0.04; p=0.001) and, conversely, was
associated with reduced risk of early infancy ‘‘failure to thrive’’
between birth and age 6 wk (OR=0.92 per allele, 0.86–0.98,
p=0.009).
Childhood Length/Height and BMI
Similar to weight SDS, an association between the obesity-risk-
allele score and length/height appeared soon after birth
(association with length at 6 wk: 0.03 SDS/allele; 95% CI 0.01–
0.05, p=0.001). However, in contrast to weight, this association
did not appear to increase in size subsequently during childhood
(Figure 2B). Longitudinal analyses confirmed that the obesity-risk-
allele score was positively associated with rate of gain in length
during early infancy (birth to 6 wk: 0.158 SDS/allele/y; 0.032–
0.284), but not subsequently (6 wk to 11 y: 0.000 SDS/allele/y;
20.001 to 0.001).
The obesity-risk-allele score was positively associated with BMI
at birth (0.02 SDS/allele; 95% CI 0.00–0.03, p=0.03), and
longitudinal analyses showed a positive association with rate of
gain in BMI between birth to age 11 y (0.006 SDS/allele/y;
0.005–0.007). However, the obesity-risk-allele score showed only
weak association with BMI SDS during infancy until age 3.5 y
Obesity Loci and Infant Growth
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onwards, from which time the association increased rapidly
(Figure 2C).
Comparison with the Ten-Variants Risk-Allele Score
Compared to the obesity-risk-allele score based on eight
genetic variants, an extended obesity-risk-allele score based on
ten variants (i.e., including genotypes at SH2B1 and MTCH2,
which were individually unrelated to childhood BMI) showed very
similar, but slightly attenuated, associations with childhood body
size and body composition (Table S4). The extended obesity-risk-
allele score was also significantly associated with infant body
weight at age 6 wk, and with conditional weight gain during the
first 6 wk of life.
Discussion
This study shows that recently established genetic variants for
adult BMI have a combined association with childhood weight
gain that is apparent even within the first weeks from birth. The
combined association between these variants and childhood BMI,
of around 0.5 SDS between the lowest and highest allele risk score
groups, was similar in size to that seen with adult BMI (1.5 kg/m2)
Table 1. Summary of growth measurements by age and sex.
Variable Boys (n=3610) Girls (n=3536)
n mean (95% CI) n mean (95% CI)
Weight (kg)
Birth 3441 3.49 (3.47–3.51) 3344 3.38 (3.37–3.40)
6 wk 3124 5.22 (5.20–5.25) 3051 4.84 (4.81–4.86)
9 mo 2839 9.53 (9.49–9.57) 2825 8.88 (8.84–8.92)
18 mo 2658 12.2 (12.2–12.3) 2606 11.6 (11.6–11.7)
42 mo 2712 16.7 (16.6–16.8) 2643 16.2 (16.1–16.3)
7 y 2650 25.8 (25.6–25.9) 2608 25.8 (25.7–26.0)
8 y 2193 30.1 (29.9–30.3) 2232 30.3 (30.0–30.5)
9 y 2401 34.3 (34.0–34.6) 2478 34.9 (34.6–35.2)
10 y 2314 37.6 (37.2–37.9) 2381 38.3 (38.0–38.6)
11 y 2170 42.5 (42.1–42.9) 2294 44.5 (44.1–44.9)
Length/Height (cm)
Birth 2737 51.1 (51.0–51.2) 2629 50.4 (50.3–50.5)
6 wk 3003 58.0 (57.9–58.1) 2930 56.9 (56.8–57.0)
9 mo 2881 73.2 (73.1–73.3) 2863 71.4 (71.3–71.5)
18 mo 2723 84.5 (84.4–84.7) 2653 83.1 (83.0–83.2)
42 mo 2708 100.9 (100.8–101.1) 2633 100.0 (99.8–100.1)
7 y 2654 126.2 (126.0–126.4) 2611 125.5 (125.3–125.7)
8 y 2277 132.9 (132.6–133.1) 2303 132.1 (131.8–132.3)
9 y 2389 139.7 (139.5–140.0) 2452 139.4 (139.1–139.6)
10 y 2307 143.9 (143.6–144.1) 2368 144.1 (143.9–144.4)
11 y 2167 150.1 (149.8–150.4) 2295 151.5 (151.2–151.8)
BMI (kg/m2)
Birth 2704 13.4 (7.1–25.6) 2601 13.3 (6.3–30.4)
6 wk 2939 15.5 (15.4–15.5) 2860 14.9 (14.9–15.0)
9 mo 2744 17.8 (17.7–17.8) 2736 17.4 (17.3–17.5)
18 mo 2572 17.1 (17.0–17.1) 2512 16.8 (16.7–16.8)
42 mo 2691 16.4 (16.3–16.4) 2624 16.2 (16.1–16.2)
7 y 2650 16.1 (16.0–16.1) 2608 16.3 (16.2–16.40)
8 y 2144 17.0 (16.9–17.0) 2180 17.3 (17.1–17.4)
9 y 2387 17.5 (17.3–17.6) 2450 17.8 (17.7–18.0)
10 y 2303 18.0 (17.9–18.1) 2363 18.3 (18.2–18.4)
11 y 2293 18.7 (18.6–18.9) 2293 19.2 (19.1–19.4)
Obese/Overweighta Obese Overweight/Obese Obese Overweight/Obese
3.9% 20.0% 4.0% 20.2%
Fat mass indexa (kg/m2) 2285 3.7 (3.6–3.8) 2331 4.9 (4.8–4.9)
Fat-free mass indexa (kg/m2) 2285 13.0 (13.0–13.1) 2331 12.1 (12.1–12.2)
aAt age 9 y.
doi:10.1371/journal.pmed.1000284.t001
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in terms of proportion of a standard deviation [6]. Therefore,
while these risk variants may well influence rate of weight gain in
adults [4], we postulate that that their relative influence on the rate
of weight gain may be greater during childhood.
Their association with weight gain was already apparent from
birth, within the first 6 weeks of life, and these adult obesity risk
alleles were, in combination, protective against poor weight gain
during the first weeks of life after birth. These findings are striking
considering that these variants were originally discovered by
association with adult BMI or obesity in populations with mean
ages ranging from 40 to 60+ years [6,7]. Other obesity
susceptibility variants in/near MAF, NPC1, PRL, and PTER [18]
have been identified in other GWA studies of early-onset and
severe obesity, and putative associations with early life weight gain
may be more expected with those variants. In addition, we
observed that the adult obesity risk alleles were also associated with
faster gains in length/height during infancy, but not during
childhood. These findings are consistent with the Karlberg model
of the endocrine regulation of childhood growth, whereby early
infancy growth in length/height is largely controlled by nutritional
factors, while the relatively stable trajectory of childhood growth
reflects the setting of the growth hormone–insulin-like growth
factor–I axis [19]. This potential weight-regulated drive in length
gain likely explains the concurrent gains in both length and weight
during infancy. Consequently, the obesity-risk-allele score showed
a weaker association with BMI than with weight until age 3.5
years.
Figure 1. Distribution of the obesity-risk-allele score in ALSPAC
children. The risk-allele score comprises genotypes at eight loci (FTO,
MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, and ETV5). Error bars
(and 2nd y-axis) display the mean (695% CI) BMI SDS at age 9 y for
each risk score value.
doi:10.1371/journal.pmed.1000284.g001
Table 2. Association of the obesity-risk-allele score with
measures of growth and adiposity at age 9 y.
Measure of Growth n
Effect Size
per Allele 95% CI P value
BMI SDS 4837 0.08 (0.06–0.10) 1.4610219
Weight SDS 4879 0.07 (0.05–0.08) 1.2610217
Height SDS 4841 0.03 (0.01–0.04) 2.561024
Fat mass indexa (kg/m2) 4616 0.13 (0.10–0.16) 1.4610213
Fat-free mass indexa (kg/m2) 4616 0.03 (0.01–0.04) 2.961024
aAdjusted for sex, age, and height.
doi:10.1371/journal.pmed.1000284.t002
Figure 2. Longitudinal associations between the obesity-risk-
allele score and (A) weight SDS, (B) length/height SDS, and (C)
BMI SDS. Regression coefficients 695% CI are shown from linear
regression models (adjusted for sex and precise age at measurement)
according to age at measurement between birth and 11 y.
doi:10.1371/journal.pmed.1000284.g002
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Rapid infancy weight gain and larger infant body weight have
been consistently related to increased risk of obesity in subsequent
childhood or adult life [20,21]. However, life-course disease studies
in historical cohort studies have provided conflicting evidence. For
example, rapid infant weight gain has been associated with
increased risk of obesity and the metabolic syndrome, but with
reduced risk of type 2 diabetes [22]. One difficulty is that studies in
historical cohorts or in societies that are undergoing nutritional
transition may identify life-course associations that are specific to
those particular settings [23]. Even in contemporary western
studies, the very long-term follow-up needed to record adult
disease outcomes may mean that current findings will not be
applicable to future infant settings. We propose that the
application in contemporary birth cohorts of genetic markers that
are robustly associated with adult disease risks may provide a novel
approach to life-course epidemiology, by identifying early
exposures that are directly relevant to current settings.
Infancy weight gain and growth are markedly influenced by
nutritional factors, such as type of milk feeding [24]. Our current
findings show that genetic factors also contribute to early weight
gain and growth. While the mechanisms of action for these obesity
variants have yet to be established, many show high levels of
expression, or have known actions, in the central nervous system
and could therefore regulate feeding behaviour [6]. However,
there is likely to be heterogeneity in their biological actions and in
their specific effects during childhood and infancy. Future
identification of the biological actions related to individual variants
will shed further light on the specific early life mechanisms that
lead to obesity. However, in view of their modest effect sizes, much
larger studies or collaborations to pool longitudinal data from
multiple birth cohorts will be needed to distinguish the specific
childhood manifestations of individual variants.
Failure to thrive in infancy, variably defined as underweight or
poor weight gain, is a multifactorial condition [25]. After exclusion
of a wide range of medical conditions, nonorganic failure to thrive
was traditionally considered to be a risk marker for maternal
rejection and neglect [26]. However, the majority of infants with
failure to thrive likely represent the lower-normal distribution of
infancy weight gain. Health professionals have increasingly
recognised the important contribution of innate differences in
infant food intake rather than simply food provision by the
caregiver [26], but until now no such infant factors have been
demonstrated. We postulate that genetic factors in the infant that
increase appetite and predispose to later obesity are protective
against infant failure to thrive.
In conclusion, greater early infancy gains in weight and length
represent the start of pathway to adult obesity risk in contempo-
rary settings. Our findings demonstrate the utility of using robust
genetic markers of disease risk to identify life-course disease
associations with current relevance.
Supporting Information
Table S1 Comparison of growth measurements in ALSPAC
with complete genotype data (‘‘Included’’) and other white
European ALSPAC children (‘‘Excluded’’).
Found at: doi:10.1371/journal.pmed.1000284.s001 (0.11 MB
DOC)
Table S2 Association of variants in BDNF and ETV5 with BMI,
weight, and height SDS at each time point.
Found at: doi:10.1371/journal.pmed.1000284.s002 (0.11 MB
DOC)
Table S3 Variance in weight SDS and BMI SDS explained by
the obesity-risk-allele score at each time point.
Found at: doi:10.1371/journal.pmed.1000284.s003 (0.03 MB
DOC)
Table S4 Comparison of obesity-risk-allele scores based on eight
and ten genetic variants.
Found at: doi:10.1371/journal.pmed.1000284.s004 (0.06 MB
DOC)
Acknowledgments
We are extremely grateful to all the families who took part in this study and
the midwives for their help in recruiting them. We thank the whole
ALSPAC team, which includes interviewers, computer and laboratory
technicians, clerical workers, research scientists, volunteers, managers,
receptionists, and nurses. We also thank Tim Frayling for supporting the
genotyping of the FTO and MC4R variants.
Author Contributions
ICMJE criteria for authorship read and met: CEE RJFL SS CL SMR NJT
ARN GDS DBD NJW KKO. Agree with the manuscript’s results and
conclusions: CEE RJFL SS CL SMR NJT ARN GDS DBD NJW KKO.
Designed the experiments/the study: RJFL GDS DBD NJW KKO.
Analyzed the data: CEE GDS KKO. Collected data/did experiments for
the study: SMR GDS NJW KKO. Enrolled patients: GDS. Wrote the first
draft of the paper: CEE KKO. Contributed to the writing of the paper:
CEE RJFL SS CL SMR NJT ARN GDS NJW KKO. This publication is
the responsibility of Ken Ong and George Davey-Smith, who had full
access to all the data in the study and take responsibility for the integrity of
the data and the accuracy of the data analysis.
References
1. Bundred P, Kitchiner P, Buchan I (2001) Prevalence of overweight and obese
children between 1989 and 1998: population based series of cross sectional
studies. BMJ 322: 326–328.
2. Dietz WH (1994) Critical periods in childhood for the development of obesity.
American Journal of Clinical Nutrition 59: 955–959.
3. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH (1997) Predicting
obesity in young adulthood from childhood and parental obesity. N Engl J Med
337: 869–873.
4. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al. (2007)
A common variant in the FTO gene is associated with body mass index and
predisposes to childhood and adult obesity. Science 316: 889–894.
5. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, et al. (2008) Common
variants near MC4R are associated with fat mass, weight and risk of obesity. Nat
Genet 40: 768–775.
6. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, et al. (2009) Six new loci
associated with body mass index highlight a neuronal influence on body weight
regulation. Nat Genet 41: 25–34.
7. Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P,
et al. (2009) Genome-wide association yields new sequence variants at seven loci
that associate with measures of obesity. Nat Genet 41: 18–24.
8. Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN (2008) An
obesity-associated FTO gene variant and increased energy intake in children.
N Engl J Med 359: 2558–2566.
9. Grant SF, Bradfield JP, Zhang H, Wang K, Kim CE, et al. (2009) Investigation
of the Locus Near MC4R With Childhood Obesity in Americans of European
and African Ancestry. Obesity (Silver Spring).
10. Golding J, Pembrey M, Jones R (2001) ALSPAC–the Avon Longitudinal Study of
Parents and Children. I. Study methodology. Paediatr Perinat Epidemiol 15: 74–87.
11. Cole TJ, Freeman JV, Preece MA (1995) Body mass index reference curves for
the UK, 1990. Arch Dis Child 73: 25–29.
12. Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, et al. (1995) Cross
sectional stature and weight reference curves for the UK, 1990. Archives of
Disease in Childhood 73: 17–24.
13. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard
definition for child overweight and obesity worldwide: international survey. Bmj
320: 1240–1243.
14. Wells JC, Cole TJ (2002) Adjustment of fat-free mass and fat mass for height in
children aged 8 y. Int J Obes Relat Metab Disord 26: 947–952.
15. Cole TJ (1995) Conditional reference charts to assess weight gain in British
infants. Arch Dis Child 73: 8–16.
Obesity Loci and Infant Growth
PLoS Medicine | www.plosmedicine.org 6 May 2010 | Volume 7 | Issue 5 | e1000284
16. Drewett R, Blair P, Emmett P, Emond A (2004) Failure to thrive in the term and
preterm infants of mothers depressed in the postnatal period: a population-based
birth cohort study. J Child Psychol Psychiatry 45: 359–366.
17. Stata. Corp (2007) Stata Statistical Software: Release 10. College Station, TX:
StataCorp LP.
18. Meyre D, Delplanque J, Chevre JC, Lecoeur C, Lobbens S, et al. (2009)
Genome-wide association study for early-onset and morbid adult obesity
identifies three new risk loci in European populations. Nat Genet 41: 157–159.
19. Karlberg J (1987) On the modelling of human growth. Stat Med 6: 185–192.
20. Ong KK, Loos RJ (2006) Rapid infancy weight gain and subsequent obesity:
systematic reviews and hopeful suggestions. Acta Paediatr 95: 904–908.
21. Baird J, Fisher D, Lucas P, Kleijnen J, Roberts H, et al. (2005) Being big or
growing fast: systematic review of size and growth in infancy and later obesity.
BMJ 331: 929.
22. Fall CH, Sachdev HS, Osmond C, Lakshmy R, Biswas SD, et al. (2008) Adult
metabolic syndrome and impaired glucose tolerance are associated with different
patterns of BMI gain during infancy: Data from the New Delhi Birth Cohort.
Diabetes Care 31: 2349–2356.
23. Stettler N (2007) Commentary: Growing up optimally in societies undergoing
the nutritional transition, public health and research challenges. Int J Epidemiol
36: 558–559.
24. Ong KK, Preece MA, Emmett PM, Ahmed ML, Dunger DB (2002) Size at birth
and early childhood growth in relation to maternal smoking, parity and infant
breast-feeding: longitudinal birth cohort study and analysis. Pediatric Research
52: 863–867.
25. Jolley CD (2003) Failure to thrive. Curr Probl Pediatr Adolesc Health Care 33:
183–206.
26. Skuse DH (1985) Non-organic failure to thrive: a reappraisal. Arch Dis Child 60:
173–178.
Obesity Loci and Infant Growth
PLoS Medicine | www.plosmedicine.org 7 May 2010 | Volume 7 | Issue 5 | e1000284
Editors’ Summary
Background. The proportion of overweight and obese
children is increasing across the globe. In the US, the
Surgeon General estimates that, compared with 1980, twice
as many children and three times the number of adolescents
are now overweight. Worldwide, 22 million children under five
years old are considered by the World Health Organization to
be overweight.
Being overweight or obese in childhood is associated with
poor physical and mental health. In addition, childhood
obesity is considered a major risk factor for adult obesity,
which is itself a major risk factor for cancer, heart disease,
diabetes, osteoarthritis, and other chronic conditions.
The most commonly used measure of whether an adult is a
healthy weight is body mass index (BMI), defined as weight in
kilograms/(height in metres)2. However, adult categories of
obese (.30) and overweight (.25) BMI are not directly
applicable to children, whose BMI naturally varies as they grow.
BMI can be used to screen children for being overweight and
or obese but a diagnosis requires further information.
Why Was This Study Done? As the numbers of obese and
overweight children increase, a corresponding rise in future
numbers of overweight and obese adults is also expected.
This in turn is expected to lead to an increasing incidence of
poor health. As a result, there is great interest among health
professionals in possible pathways between childhood and
adult obesity. It has been proposed that certain periods in
childhood may be critical for the development of obesity.
In the last few years, ten genetic variants have been found to
be more common in overweight or obese adults. Eight of these
have also been linked to childhood BMI and/or obesity. The
authors wanted to identify the timing of childhood weight
changes that may be associated with adult obesity. Knowledge
of obesity risk genetic variants gave them an opportunity to do
so now, without following a set of children to adulthood.
What Did the Researchers Do and Find? The authors
analysed data gathered from a subset of 7,146 singleton
white European children enrolled in the Avon Longitudinal
Study of Parents and Children (ALSPAC) study, which is
investigating associations between genetics, lifestyle, and
health outcomes for a group of children in Bristol whose due
date of birth fell between April 1991 and December 1992.
They used knowledge of the children’s genetic makeup to
find associations between an obesity risk allele score—a
measure of how many of the obesity risk genetic variants a
child possessed—and the children’s weight, height, BMI,
levels of body fat (at nine years old), and rate of weight gain,
up to age 11 years.
They found that, at birth, children with a higher obesity risk
allele score were not any heavier, but in the immediate
postnatal period they were less likely to be in the bottom 5%
of the population for weight gain (adjusted for birthweight),
often termed ‘‘failure to thrive.’’ At six weeks of age, children
with a higher obesity risk allele score tended to be longer
and heavier, even allowing for weight at birth.
After six weeks of age, the obesity risk allele score was not
associated with any further increase in length/height, but it
was associated with a more rapid weight gain between birth
and age 11 years. BMI is derived from height and weight
measurements, and the association between the obesity risk
allele score and BMI was weak between birth and age three-
and-a-half years, but after that age the association with BMI
increased rapidly. By age nine, children with a higher obesity
risk allele score tended to be heavier and taller, with more fat
on their bodies.
What Do These Findings Mean? The combined obesity
allele risk score is associated with higher rates of weight gain
and adult obesity, and so the authors conclude that weight
gain and growth even in the first few weeks after birth may
be the beginning of a pathway of greater adult obesity risk.
A study that tracks a population over time can find associations
but it cannot show cause and effect. In addition, only a
relatively small proportion (1.7%) of the variation in BMI at nine
years of age is explained by the obesity risk allele score.
The authors’ method of finding associations between
childhood events and adult outcomes via genetic markers
of risk of disease as an adult has a significant advantage: the
authors did not have to follow the children themselves to
adulthood, so their findings are more likely to be relevant to
current populations. Despite this, this research does not yield
advice for parents how to reduce their children’s obesity risk.
It does suggest that ‘‘failure to thrive’’ in the first six weeks of
life is not simply due to a lack of provision of food by the
baby’s caregiver but that genetic factors also contribute to
early weight gain and growth.
The study looked at the combined obesity risk allele score
and the authors did not attempt to identify which individual
alleles have greater or weaker associations with weight gain
and overweight or obesity. This would require further
research based on far larger numbers of babies and children.
The findings may also not be relevant to children in other
types of setting because of the effects of different nutrition
and lifestyles.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000284.
N Further information is available on the ALSPAC study
N The UK National Health Service and other partners provide
guidance on establishing a healthy lifestyle for children
and families in their Change4Life programme
N The International Obesity Taskforce is a global network of
expertise and the advocacy arm of the International
Association for the Study of Obesity. It works with the
World Health Organization, other NGOs, and stakeholders
and provides information on overweight and obesity
N The Centers for Disease Control and Prevention (CDC) in
the US provide guidance and tips on maintaining a healthy
weight, including BMI calculators in both metric and
Imperial measurements for both adults and children. They
also provide BMI growth charts for boys and girls showing
how healthy ranges vary for each sex at with age
N The Royal College of Paediatrics and Child Health provides
growth charts for weight and length/height from birth to
age 4 years that are based on WHO 2006 growth standards
and have been adapted for use in the UK
N The CDC Web site provides information on overweight and
obesity in adults and children, including definitions,
causes, and data
N The CDC also provide information on the role of genes in
causing obesity.
N The World Health Organization publishes a fact sheet on
obesity, overweight and weight management, including
links to childhood overweight and obesity
N Wikipedia includes an article on childhood obesity (note
that Wikipedia is a free online encyclopedia that anyone
can edit; available in several languages)
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